Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 47 (RPL36AP47)
- Target
- RPL36AP47
- Molecular classification
- Other (Processed pseudogene; not a member of established druggable families like GPCRs, kinases, enzymes, etc.)
01
Overview
Ribosomal protein L36a pseudogene 47 (RPL36AP47) is a processed pseudogene in the human genome with sequence similarity to the functional ribosomal protein gene RPL36A. Unlike protein-coding genes, RPL36AP47 does not produce a functional protein. Pseudogenes like RPL36AP47 may have regulatory RNA functions, such as acting as competitive endogenous RNAs or miRNA sponges, but they do not have direct enzymatic, transporter, receptor, or transcription factor activity. There are no known diseases directly associated with RPL36AP47, nor are any therapeutic drugs known to target this pseudogene. In general, the ribosomal protein pseudogene family has been explored for potential regulatory roles in cancer and immune function, but specific evidence for RPL36AP47 is lacking[1][7][10].
- Other names
- RPL36A_22_1567RPL36AP47
02
Mechanism of action
Not applicable; no drugs target this pseudogene directly
03
Biological functions
Possible regulatory role in gene expression by acting as a competitive endogenous RNA (ceRNA) or miRNA sponge, based on pseudogene functions in generalMay influence the parent gene (RPL36A) via RNA-mediated regulatory mechanisms.No established role in protein synthesis or other canonical cell functions
04
Disease associations
As with other ribosomal protein pseudogenes, may have an indirect regulatory role associated with cancer and immune disorders as suggested for other pseudogenesNo direct disease role established for RPL36AP47; but ribosomal protein pseudogenes have been implicated as regulatory elements in malignancy
05
Safety considerations
None; no therapeutic interventions known or planned for this pseudogene
06
Interacting drugs
None known; pseudogenes are not known to be targets of drugs directly
07
Biomarkers
None established for RPL36AP47 specifically; processed pseudogenes are sometimes explored as RNA biomarkers, but no clinical utility reported for this pseudogene
Beyond the preview
Go deeper on Ribosomal protein L36a pseudogene 47 (RPL36AP47).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 47 (RPL36AP47).